Id: CBI_1704 | Pages: 281 | Format : PDF | Published : | Author : Amit Sati | Category : Healthcare
Mammography Market size is growing with a CAGR of 9.1% during the forecast period (2024-2031), and the market is projected to be valued at USD 4,793.44 Million by 2031 from USD 2,397.50 Million in 2023.
Mammography is a medical imaging technique that uses a low-dose x-ray system to examine the breast for the early detection of cancer. It is used as both a screening and diagnostic tool. It creates detailed images of the breast tissue, aiding in the identification of abnormalities such as lumps, microcalcifications, or other changes that indicate the presence of cancerous or benign conditions. It encompasses two categories of these systems including analog and digital systems. An analog system is a traditional method that involves capturing images on film. It has largely been replaced by digital mammography due to its limitations in terms of image quality, storage, and analysis. Digital systems employ detectors to convert X-rays into digital images that are stored, analyzed, and transmitted electronically. Digital system offers several advantages including the ability to manipulate and enhance images for better visualization, easier storage and retrieval, and the potential for computer-aided detection systems to assist radiologists in identifying potential abnormalities.
The rising cases of breast cancer are one of the prominent reasons fuelling the requirement for mammography which is driving the market growth worldwide. Breast cancer is a disease in which abnormal breast cells grow uncontrollably and form tumors. The growing incidences of breast cancer are attributed to multiple risk factors including increasing age, obesity, family history of breast cancer, history of radiation exposure, reproductive history, genetic predisposition, and postmenopausal hormone therapy among others. The increasing prevalence of breast cancer is propelling the requirement for these techniques.
The high predisposition risk factors have led to a larger number of at-risk individuals requiring regular screening. Additionally, the fright of spreading tumors throughout the body and becoming fatal is a predominant factor creating the requirement for highly accurate diagnostic solutions. Thus, the increasing prevalence of breast cancer with the availability of mammography technologies, is driving the market globally.
Rising awareness about the importance of regular screening and early detection of breast cancer is a major factor creating the adoption of mammography. Early detection of cancer significantly improves treatment outcomes and survival rates of patients. Increasing awareness campaigns and initiatives by healthcare organizations, governments, and non-profit groups to educate women regarding the importance of regular mammograms is significantly boosting the demand.
This influences healthcare providers to invest in cutting-edge diagnostic solutions. As a result, the collective efforts by the leading authorities for the awareness of screening and early detection of breast cancer are significantly boosting the requirement for these systems, thereby driving market growth across the globe.
The market is experiencing significant constraints due to increasingly stringent regulations that hamper the industry’s growth and profitability. The stringent regulatory environment governing the development, approval, and commercialization of medical devices, including mammography significantly impacts market growth. A few of the regulatory bodies are the FDA (Food and Drug Administration) in the US and the EMA (European Medicines Agency) in Europe which impose stringent requirements on manufacturers to ensure the safety and efficacy of medical devices.
These stringent regulations lead to increased development costs, longer approval timelines, and complex compliance processes. Manufacturers must invest substantial resources in clinical trials, regulatory documentation, and quality assurance systems to obtain regulatory approval. This delays product launches and limits market entry for new and innovative technologies. Additionally, regulatory changes and updates create uncertainty and add to the complexity of the regulatory landscape. Thus, as per the analysis, the impact of these stringent regulations on the mammography market expansion is multifaceted.
The need for early detection and accurate diagnosis of breast cancer is leading to the development of technologically advanced systems. Advancements such as computer-aided diagnosis, 3D mammography, and the use of artificial intelligence are improving accuracy. Computer-aided detection (CAD) is a computer program that helps radiologists interpret mammograms by highlighting abnormal areas. CAD uses pattern recognition to mark suspicious areas, such as masses, calcifications, and asymmetries, for the radiologist to review.
Additionally, artificial intelligence (AI) is rapidly being incorporated, with AI-powered algorithms analyzing mammograms for automated detection of suspicious areas and risk assessment tools helping to personalize screening strategies for individual patients. Contrast-enhanced mammography (CEM) is another emerging technology that utilizes a contrast agent to enhance the visualization of tumors and improve diagnostic accuracy. The increasing efforts taken by the leading manufacturers to provide advanced systems are expected to propel the market growth.
Overall, the integration of advanced technologies in these systems is expected to create the need for innovation in the market, ultimately leading to improved patient care and earlier cancer detection.
Based on product type, the market is bifurcated into analog and digital systems.
Trends in the Product Type:
The digital mammography system segment accounted for the largest market share in 2023 and is also expected to grow at the fastest CAGR over the forecast period.
Based on the application, the market is bifurcated into screening and diagnostic mammography.
Trends in the Application:
The screening mammography segment accounted for the largest market share in the year 2023.
The diagnostic mammography segment is expected to grow at the fastest CAGR over the forecast period.
Based on end users, the market is categorized into hospitals, ambulatory surgery centers, diagnostic centers, and others.
Trends in the End User:
The hospitals segment accounted for the largest mammography market share of 50.02% in the year 2023.
The diagnostic centers segment is expected to grow at the fastest CAGR over the forecast period.
The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2023, North America accounted for the highest market share at 38.91% and was valued at USD 932.87 Million and is expected to reach USD 1,768.30 Million in 2031. In North America, the U.S. accounted for the highest share of 69.31% during the base year of 2023.
The North American region holds the dominant position in the mammography market share owing to factors such as the increasing prevalence of breast cancer, the presence of well-developed healthcare systems, and the accessibility of technologically advanced systems. Additionally, the rising awareness of breast cancer and proactive screening practices are driving the need for advanced systems.
The region boasts widespread adoption of regular mammograms due to extensive public health campaigns and insurance coverage for preventive care. The region has a strong focus on early detection and preventive healthcare, leading to a high requirement for mammography for early diagnosis of breast cancer.
Additionally, the presence of key market players and regulatory support contribute to the market's trajectory. Thus, the combination of advanced healthcare infrastructure, strong government initiatives, and increasing awareness about breast cancer has solidified North America's leading position in the global mammography market trend.
Asia Pacific is experiencing the fastest growth with a CAGR of 11.0% over the forecast period. As per the mammography market analysis, this region is experiencing a rise fueled by increasing healthcare expenditure, rising awareness about breast cancer, and a growing geriatric population. Countries including China, India, and Japan are witnessing significant investments in healthcare infrastructure and the adoption of advanced medical technologies. Additionally, government initiatives to promote early detection and preventive healthcare are contributing to the market's trajectory. Governments in several countries are launching awareness campaigns to educate women about the importance of early breast cancer detection. Thus, as the healthcare landscape in the Asia Pacific region continues to evolve, the requirement for services is expected to grow steadily, offering mammography market opportunities.
Europe is a significant player in the global mammography market demand characterized by a well-established healthcare infrastructure with a focus on early detection and preventive care and a strong regulatory framework. Countries including Germany, France, and the UK have well-established healthcare systems, healthcare industry, and strong government initiatives for breast cancer screening. The region has a high prevalence of breast cancer, leading to a significant requirement for diagnostic and screening systems. Many European countries have implemented national screening programs to encourage regular breast cancer screening. These programs often include mammography as a key component, further boosting market demand. Moreover, the increasing adoption of advanced technologies is further driving the mammography market.
Based on mammography market analysis, the Middle East and Africa region presents a complex and diverse landscape. Increasing healthcare expenditure and government initiatives are driving market trajectory. Additionally, the burgeoning healthcare sector in the Middle East is playing a pivotal role in the mammography market trend. Countries in this region are investing heavily in modern healthcare infrastructure and advanced medical technologies. This increased investment is facilitating the development of hospitals, diagnostic centers, and ambulatory centers. The combined impact of these factors is creating a favorable environment for the trajectory of the market in the MEA region.
Latin America is an emerging region for the mammography market, driven by factors such as increasing healthcare expenditure, rising awareness about breast cancer, and the growing middle class. Countries including Brazil and Mexico are witnessing significant investments in healthcare infrastructure and the adoption of advanced medical technologies. Investments in healthcare infrastructure, particularly in urban areas, are improving access to diagnostic services. These factors collectively present a promising mammography market opportunity for healthcare providers and medical device manufacturers to develop and deliver innovative systems to address the needs of individuals with breast cancer in Latin America.
The mammography market is highly competitive with major players providing products to the national and international markets. Key players are adopting several strategies in research and development (R&D) and product innovation to hold a strong position in the global mammography market. Key players in the mammography industry include-
Product Approval:
New Launch:
Report Attributes | Report Details |
Study Timeline | 2018-2031 |
Market Size in 2031 | USD 4,793.44 Million |
CAGR (2024-2031) | 9.1% |
By Product Type |
|
By Application |
|
By End-User |
|
By Region |
|
Key Players |
|
North America | U.S. Canada Mexico |
Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
Middle East and Africa | GCC Turkey South Africa Rest of MEA |
LATAM | Brazil Argentina Chile Rest of LATAM |
Report Coverage |
|
In 2023, the Mammography market is USD 2,397.50 Million.
Asia Pacific is the fastest-growing region in the Mammography market.
Product Type, Application, and end-user segmentation details are covered in the Mammography market.
Siemens Healthcare Private Limited (Germany), GE HealthCare (U.S), and SternMed GmbH. (Germany) are some of the major players in the market.